CASI Pharmaceuticals Inc. (CASI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
1.85
0.10 (5.71%)
At close: Oct 03, 2025, 3:59 PM
1.90
2.68%
After-hours: Oct 03, 2025, 06:52 PM EDT

CASI Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.17M 6.24M 13.36M 7.79M 3.98M 3.41M 6.09M 8.84M 9.82M 8.35M 15.26M 10.21M 8.57M 9.06M 9.16M 8.11M 7.16M 5.74M
Cost of Revenue
2.12M 2.62M 10.13M 3.75M 1.91M 1.6M 2.27M 3.65M 3.99M 3.38M 4.27M 4.25M 3.55M 3.76M 3.8M 3.42M 2.98M 2.36M
Gross Profit
2.06M 3.62M 3.23M 4.04M 2.07M 1.81M 3.82M 5.19M 5.83M 4.97M 10.99M 5.97M 5.02M 5.3M 5.36M 4.7M 4.18M 3.38M
Operating Income
-11.13M -10.38M -12.91M -8.46M -8.79M -9.22M -10.2M -5.09M -9.35M -7.21M 11.65M -6.35M -7.75M -7.29M -11.37M -6.89M -7.98M -15.6M
Interest Income
45K 77K n/a n/a 135K 131K 112K 161K 139K 202K 26K 13K 40K 74K 60K 79K 76K 106K
Pretax Income
-11.2M -10.75M -14.37M -7.28M -6.96M -9.53M -5.38M -4.45M -10.05M -5.81M -16.52M -5.02M -7.49M -8.4M -5.39M -10.02M -6.74M -13.68M
Net Income
-13.38M -10.75M -14.37M -8.39M -6.96M -9.53M -6.05M -4.63M -10.24M -6.01M -18.5M -3.87M -7.68M -9.71M -5.6M -10.22M -6.95M -13.88M
Selling & General & Admin
11.04M 11.92M 11.92M 10.61M 10.37M 8.55M 11.57M 8.04M 12.52M 9.71M 11.84M 8.41M 8.92M 8.6M 12.78M 8.69M 8.78M 8.22M
Research & Development
1.72M 1.94M 3.67M 1.52M 1.25M 2.48M 2.31M 2.4M 2.61M 2.53M 4.25M 3.9M 3.85M 3.99M 4.01M 2.9M 2.25M 5.26M
Other Expenses
415K 141K 558K 379K -765K n/a 131K n/a 89K n/a -16K 11K 11K 38K 18K n/a 33K 20K
Operating Expenses
13.18M 14M 16.14M 12.51M 10.86M 11.03M 14.02M 10.44M 15.13M 12.24M 16.09M 12.32M 12.77M 12.59M 16.79M 11.59M 11.04M 13.47M
Interest Expense
244K 197K 694K 61K 55K 192K n/a n/a n/a n/a 29.2M 13K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
4.96M 4.22M 4.8M 4.91M 4.42M 3.74M 5.15M 2.52M 4.82M 3.96M 4.08M 3.57M 3.4M 3.28M 5.2M 3.43M 3.36M 2.71M
Cost & Expenses
15.3M 16.62M 26.27M 16.26M 12.77M 12.63M 16.29M 14.09M 19.12M 15.62M 20.36M 16.57M 16.32M 16.35M 20.59M 15M 14.02M 15.83M
Income Tax Expense
2.17M n/a 73K 1.12M n/a n/a 1K 176K 1K 52K 1.98M -1.15M n/a 1.31M 812K n/a n/a n/a
Shares Outstanding (Basic)
15.51M 15.49M 15.49M 15.29M 13.52M 13.38M 13.38M 13.38M 13.34M 13.34M 13.46M 13.61M 13.61M 13.8M 13.8M 13.98M 13.89M 12.48M
Shares Outstanding (Diluted)
15.51M 15.49M 15.49M 15.29M 13.52M 13.38M 13.38M 13.38M 13.34M 13.34M 13.46M 13.61M 13.61M 13.8M 13.8M 13.98M 13.98M 12.48M
EPS (Basic)
-0.86 -0.69 -0.93 -0.55 -0.52 -0.71 -0.45 -0.35 -0.77 -0.45 -1.45 -0.38 -0.56 -0.62 -0.41 -0.73 -0.5 -1.11
EPS (Diluted)
-0.86 -0.69 -0.93 -0.55 -0.52 -0.71 -0.45 -0.35 -0.77 -0.45 -1.45 -0.38 -0.56 -0.62 -0.41 -0.73 -0.5 -1.11
EBITDA
-10.96M -10.55M -10.34M -7.15M -8.62M -8.28M -2.52M -4.64M -8.7M -6.67M -4.21M -5.59M -7.41M -6.86M -10.89M -6.47M -6.46M -9.58M
EBIT
-10.96M -10.55M -10.34M -8.09M -9.55M -9.22M -3.46M -5.25M -9.3M -7.27M -5.1M -6.35M -7.75M -7.29M -11.44M -6.89M -6.92M -10.1M
Depreciation & Amortization
n/a n/a 582.75K 935.25K 935.25K 935.25K 935.25K 605.5K 605.5K 605.5K 890K 1.01M 669K 741K 662K 765K 804K 864K